SSB Triazole-resistant Aspergillus fumigatus CRF

SSB Triazole-resistant Aspergillus fumigatus CRF.docx

Triazole-resistant Aspergillus fumigatus Case Report Form

OMB: 0920-1385

Document [docx]
Download: docx | pdf






Triazole-resistant Aspergillus fumigatus Case Report Form

Request for OMB approval of a New Information Collection


May 6, 2022









Supporting Statement B




















Contact:

Thomas J. “Chip” Daymude

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

1600 Clifton Road, NE

Atlanta, Georgia 30333

Phone: (470) 553-3567

Email: qkh7@cdc.gov

Table of Contents



1. Respondent Universe and Sampling Methods 2

2. Procedures for the Collection of Information 2

3. Methods to maximize Response Rates and Deal with No Response 2

4. Tests of Procedures or Methods to be Undertaken 2

5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data 2



The collection does not involve statistical methods. Making statistical generalizations beyond the particular respondents is not the purpose of the collection.

  1. Respondent Universe and Sampling Methods

The collection is a convenience sample of patients who test positive for triazole-resistant Aspergillus fumigatus. Respondents are public health officials/clinicians who will fill out a case report form regarding patients who test positive for triazole-resistant Aspergillus fumigatus. Patients might come from any U.S. healthcare facility.

  1. Procedures for the Collection of Information

The collection is a convenience sample of patients who test positive for triazole-resistant Aspergillus fumigatus. For patients involving triazole-resistant isolates, CDC would use a standardized case report form (CRF) to characterize demographics (e.g., race/ethnicity, country of residence) underlying medical conditions, treatments, and outcomes (e.g., vital status at 30 days for initial positive specimen). The CRF would be filled out voluntarily by state and local health departments and contains an optional supplement at the end involving a brief interview (including data on occupational and environmental exposures) of a patient or their representative.

  1. Methods to maximize Response Rates and Deal with No Response

Not applicable

  1. Tests of Procedures or Methods to be undertaken

No pretests are planned

  1. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data

None.


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorSamuel, Lee (CDC/OID/NCEZID)
File Modified0000-00-00
File Created2022-06-08

© 2024 OMB.report | Privacy Policy